Study: Cataloging DNA Reveals Roots of Disease - Diverse Health

Higher Education News and Jobs

Study: Cataloging DNA Reveals Roots of Disease

Email
   
        


by Malcolm Ritter, Associated Press

NEW YORK A huge catalog of human DNA is helping researchers find tiny glitches that cause disease, in part by pointing out some false leads.

The database, with genetic codes from more than 60,000 people, is aimed at researching rare diseases that are generally caused by a single malfunctioning gene. Most of these diseases are so uncommon that the general public has never heard of them, but there are thousands of such conditions, and as a group they affect about 1 percent of births.

Better accuracy in identifying the genetic cause of a person’s disease provides a “clear and direct benefit to patients,” said Daniel MacArthur of the Broad Institute in Cambridge, Massachusetts, and Massachusetts General Hospital in Boston.

He is senior author of an analysis published in the journal Nature by researchers who compiled the database, which draws on DNA data from more than two dozen disease studies. It went online in 2014 and has since been consulted more than 5 million times, he said.

For rare diseases, doctors try to find the genetic cause by analyzing the patient’s DNA. But everybody carries tens of thousands of minute differences from the standard DNA code, and the goal is to find which one or two of them is making the person sick.

VARIATIONS HOLD CLUES

Researchers frequently do that through guilt by association. If a variation shows up in a patient, but it is never seen or extremely rare in others, it may be fingered as the cause of disease.

The challenge is getting enough DNA from the general public. If the sampling is too small or not comprehensive enough for diverse populations, a variant may be wrongly blamed as the cause of the patient’s problems. A better sampling might show the variant actually appears in healthy people often enough that it’s clearly not making anybody sick.

False leads can harm patient care, including in some cases missing out on treatments, MacArthur said.

An example of such a “genetic misdiagnosis” was presented in an unrelated study in the New England Journal of Medicine. It focused on an inherited disease called hypertrophic cardiomyopathy, which thickens heart muscle and can interfere with pumping blood.

Examining three years of records from a testing lab, it found that seven patients were told they carried one of two DNA variants that had been linked to the heart disease. Both variants were later reclassified as benign.
At least five of the patients were of African ancestry. If the original studies of those variants had included enough black Americans in their samples, they probably would not have reached the wrong conclusion, the Harvard researchers said.

BROADER SAMPLE CATALOGED

They said the new DNA catalog, dubbed ExAC, is well-equipped to avoid such errors. It provides a far more comprehensive collection of DNA variations than has been available in the past. The roughly 10 million tiny variations listed are from people of European, African, South Asian, East Asian and Latino ancestry.

In a separate study, released by the journal Genetics in Medicine, British authors used ExAC data to cast doubt on recent reports that implicated some genes in hypertrophic cardiomyopathy and a second heart muscle disease.

The analysis in Nature provided another example of how ExAC can point out past mistakes. Researchers looked at 192 DNA variations that had been linked to diseases, but which ExAC showed were actually so common in the general population that those links appeared spurious.

The researchers found that under standard criteria, at least 163 should be reclassified as benign or probably benign. As of last December, 126 had been reclassified, the researchers reported. That probably reflects the influence of the ExAC database, MacArthur said.

But databases even bigger than ExAC will be needed to decisively link genetic variations to disease or rule them out, he said. “We have a long way to go,” he said.

Jay Shendure, a genetics expert at the University of Washington in Seattle who didn’t participate in the new work, said the ExAC catalog offers advantages over previous databases. There’s “little doubt” that it will accelerate and refine the search for disease causes and genetic aspects of patient care, he wrote in a Nature commentary.

Comments

Print Friendly

Related Articles

Addressing Indian Health Disparities: Q&A Donald Warne, MD, MPH, is the chair of the Department of Public Health at North Dakota State University and an adjunct clinical professor at the Arizona State University Sandra Day O’Connor College of Law, where he taught American Indian Health Polic...
Organ Donors Save Lives in Indian Country More than 1,100 American Indians and Alaska Natives are waiting for someone to donate the organ that will save their lives. Most—986—are waiting for a kidney, according to the U.S. Department of Health and Human Services’ Organ Procurement and Transp...
Women in Military Face Health Risks As more women join the military in ever-expanding roles, it’s important for health care providers to understand the different health needs and risks associated with their service, health care specialists told about 50 providers from eastern North Car...
Transgender Teens at High Risk of Substance Abuse A new study from Chapman University has found that transgender teenagers are twice as likely as their cisgender peers to have substance abuse problems. The study, published in the Journal of School Health, looked at data concerning trans students ...